PIDapalooza

PIDapalooza
Name	PIDapalooza
Status	Active
Genre	Conference
Frequency	Annual
Venue	Various
Location	Global
First	2010s
Organizer	Community volunteers

PIDapalooza

PIDapalooza is an annual community-driven conference and festival focused on Primary Immune Deficiency (PID), bringing together patients, clinicians, researchers, advocates, and industry representatives. The event combines formal presentations, workshops, patient panels, and social activities to foster networking among participants from institutions, foundations, hospitals, and academic centers. It emphasizes patient-centered care, translational science, advocacy, and community support across international organizations and local chapters.

Overview

PIDapalooza convenes stakeholders affiliated with institutions such as the National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, Gulf Cooperation Council, Oxford University, Harvard Medical School, Stanford University School of Medicine, Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, UCLA Health, University of California, San Francisco, Imperial College London, Karolinska Institute, Charité – Universitätsmedizin Berlin, University of Toronto, McGill University, University of Sydney, University College London, King's College London, University of Chicago Medicine, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Center, Seattle Children's Hospital, Boston Children's Hospital, Great Ormond Street Hospital, St. Jude Children's Research Hospital, Rady Children's Hospital, Toronto General Hospital, Sheba Medical Center, Tel Aviv Sourasky Medical Center, All India Institute of Medical Sciences, Aga Khan University Hospital, Oslo University Hospital, Hôpital Necker–Enfants Malades, Hospital for Sick Children, Toronto, Vanderbilt University Medical Center, University of Pennsylvania Health System, Yale New Haven Hospital and patient organizations such as the Immune Deficiency Foundation, Jeffrey Modell Foundation, European Society for Immunodeficiencies, World Primary Immunodeficiency Week organizers, National Organization for Rare Disorders, Global Genes, Rare Diseases Clinical Research Network and regional advocacy groups.

History

The conference evolved from grassroots gatherings of patients and clinicians in the 2010s, influenced by networks and meetings hosted by entities including the American Academy of Allergy, Asthma & Immunology, European Academy of Allergy and Clinical Immunology, American College of Allergy, Asthma & Immunology, British Society for Immunology, American Society of Hematology, International Congress of Immunology, European Society of Clinical Microbiology and Infectious Diseases and university symposia. Early organizers drew inspiration from patient-led initiatives associated with figures and institutions such as Delaware Valley Rare Disease advocates, philanthropic efforts from the Bill & Melinda Gates Foundation, collaborations with researchers from National Institute of Allergy and Infectious Diseases, and policy discussions involving lawmakers linked to rare disease legislation like the Orphan Drug Act. Over successive meetings, the event formalized volunteer committees, advisory boards with clinicians from centers including Mayo Clinic and Johns Hopkins Hospital, and partnerships with foundations such as the Wellcome Trust and corporate sponsors from biotechnology and pharmaceutical firms.

Format and Activities

Programming typically features keynote lectures, scientific sessions, patient panels, workshops, poster sessions, and breakout groups facilitated by clinicians and researchers from Harvard Medical School, Stanford University School of Medicine, Johns Hopkins School of Medicine, University of Oxford, Karolinska Institutet, Imperial College London, University of Toronto, University of California, San Francisco and hospitals like Great Ormond Street Hospital and Boston Children's Hospital. Practical activities have included newborn screening advocacy workshops tied to state public health departments and specialists from Centers for Disease Control and Prevention, training sessions on immunoglobulin replacement facilitated by nurse educators from Mayo Clinic and infusion specialists from Cleveland Clinic, and sessions on hematopoietic stem cell transplantation with input from teams at St. Jude Children's Research Hospital and Fred Hutchinson Cancer Center. Social events often mirror community-building models used by organizations such as Patient-Centered Outcomes Research Institute and National Organization for Rare Disorders.

Community and Participants

Participants include patients, family members, pediatric and adult immunologists, geneticists, transplant physicians, infectious disease specialists, nurses, social workers, policy advocates, researchers, industry representatives, and journalists associated with outlets like Nature Medicine, The Lancet, New England Journal of Medicine, Science, JAMA, BMJ and patient blogs. Community chapters and networks represented often originate from institutions and organizations such as the Immune Deficiency Foundation, Jeffrey Modell Foundation, regional hospitals like Seattle Children's Hospital and Rady Children's Hospital, and academic labs from University of Pennsylvania, Yale University, Columbia University Irving Medical Center, University of Michigan and Washington University School of Medicine. International participation draws members from networks affiliated with European Society for Immunodeficiencies, national health systems like the National Health Service (England), and advocacy groups linked to the World Health Organization.

Notable Events and Speakers

Keynotes and panels have featured clinicians and researchers affiliated with National Institute of Allergy and Infectious Diseases, faculty from Harvard Medical School and Stanford University, patient advocates connected to the Jeffrey Modell Foundation and Immune Deficiency Foundation, and representatives from philanthropic organizations like the Gates Foundation and Wellcome Trust. Sessions have included collaborative workshops with professionals from Mayo Clinic, Johns Hopkins Hospital, Great Ormond Street Hospital, Karolinska Institute and Imperial College London, and policy briefings involving contacts from agencies such as the Centers for Disease Control and Prevention and European Commission delegates addressing rare disease strategies.

Impact and Reception

Organizers and attendees cite outcomes including strengthened patient networks, increased awareness in clinical centers like Boston Children's Hospital and Seattle Children's Hospital, collaborations between research teams at Stanford University and University of Oxford, enhanced advocacy aligned with groups like National Organization for Rare Disorders and Global Genes, and dissemination of educational resources through platforms used by journals such as The Lancet and Nature. Coverage has appeared in specialty press, patient newsletters produced by organizations like the Immune Deficiency Foundation and briefing materials used by policymakers associated with initiatives such as World Primary Immunodeficiency Week.

Organization and Funding

The event is typically organized by volunteer committees drawing members from patient organizations including the Immune Deficiency Foundation and Jeffrey Modell Foundation, clinicians from academic centers such as Mayo Clinic, Johns Hopkins Hospital and Harvard Medical School, and nonprofit partners like the National Organization for Rare Disorders. Funding sources often include registration fees, sponsorships from biotechnology and pharmaceutical companies, grants from philanthropic entities such as the Bill & Melinda Gates Foundation and Wellcome Trust, and in-kind support from hospital partners including Cleveland Clinic and Massachusetts General Hospital.

Category:Medical conferences